首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
【24h】

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.

机译:结肠癌肝转放酶中尿激酶,尿激酶受体和纤溶酶原激活剂抑制剂-1的两个不同的表达模式。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Metastatic growth and invasion by colon cancer cells in the liver requires the ability of the cancer cells to interact with the new tissue environment. Plasmin(ogen) is activated on cell surfaces by urokinase-type PA (uPA), and is regulated by uPAR and plasminogen activator inhibitor-1 (PAI-1). To compare the expression patterns of uPA, uPAR and PAI-1 in colon cancer with that in their liver metastases, we analysed matched samples from 14 patients. In all 14 primary colon cancers, we found upregulation of uPAR, uPA mRNA and PAI-1 in primarily stromal cells at the invasive front. In 5 of the 14 liver metastases, we found intense expression of uPAR, uPA-mRNA and PAI-1 in primarily stromal cells at the metastases periphery, and in an expression pattern similar to that found in the primary tumours. In the remaining 9 liver metastases, uPAR and uPA-mRNA were only seen associated with the presence of necrosis within the liver metastases. In addition, PAI-1-immunoreactivity was in all liver metastases seen inhepatocytes at the metastases periphery. Interestingly, the former 5 liver metastases positive for uPAR, uPA mRNA and PAI-1 at the metastasis periphery all had a predominantly desmoplastic reaction, whereas 8 of the remaining 9 showed direct contact between the cancer cells and the liver parenchyma. We conclude that there are 2 distinct patterns of expression of uPAR, uPA and PAI-1 in colon cancer liver metastases and that these correlate closely with 2 morphological growth patterns. These findings may have implication for the treatment of patients with metastatic disease.
机译:肝脏中结肠癌细胞的转移生长和侵袭需要癌细胞与新的组织环境相互作用的能力。通过尿激酶型PA(UPA)在细胞表面上激活纤溶酶(ELOGEN),并通过UPAR和纤溶酶原激活剂抑制剂-1(PAI-1)调节。为了将UPA,Upar和Pai-1中的表达模式进行比较,在其肝脏转移中,我们分析了14名患者的匹配样品。在所有14个主要结肠癌中,我们发现在侵入前部的主要基质细胞中uPAR,UPA mRNA和PAI-1的上调。在14个肝脏转移中的5中,我们发现uPAR,UPA-mRNA和PAI-1的强烈表达,主要在转移外部的基质细胞中,并且以与主要肿瘤中的相似的表达模式。在剩余的9个肝转移酶中,乌马尔和UPA-mRNA仅被视为与肝转移酶内坏死的存在相关。此外,PAI-1-免疫反应性在所有肝脏转移中看到在转移外周期的肝癌。有趣的是,在转移外围的uPAR,UPA mRNA和PAI-1中的前5个肝转移阳性阳性均具有主要的去制剂反应,而剩余9的8个在癌细胞和肝脏薄壁症之间显示出直接接触。我们得出结论,在结肠癌肝转移中有2种uPAR,UPA和PAI-1表达的不同模式,并且这些与2个形态生长模式紧密相关。这些发现可能对治疗转移性疾病的患者有所意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号